UA10276A - Method for treating multiple sclerosis - Google Patents

Method for treating multiple sclerosis

Info

Publication number
UA10276A
UA10276A UA95041855A UA95041855A UA10276A UA 10276 A UA10276 A UA 10276A UA 95041855 A UA95041855 A UA 95041855A UA 95041855 A UA95041855 A UA 95041855A UA 10276 A UA10276 A UA 10276A
Authority
UA
Ukraine
Prior art keywords
multiple sclerosis
treating multiple
biostimulators
ttp
intraperitoneally
Prior art date
Application number
UA95041855A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Миколайович Макаренко
Александр Николаевич Макаренко
Світлана Володимирівна Кравченко
Светлана Владимировна Кравченко
Анатолій Павлович Чуприков
Анатолий Павлович Чуприков
Вікторія Миколаївна Миртовська
Виктория Николаевна Миртовская
Original Assignee
Київський Науково-Дослідний Інститут Загальної Та Судової Психіатрії
Киевский Научно-Исследовательский Институт Общей И Судебной Психиатрии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Київський Науково-Дослідний Інститут Загальної Та Судової Психіатрії, Киевский Научно-Исследовательский Институт Общей И Судебной Психиатрии filed Critical Київський Науково-Дослідний Інститут Загальної Та Судової Психіатрії
Priority to UA95041855A priority Critical patent/UA10276A/en
Publication of UA10276A publication Critical patent/UA10276A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the medicine, namely to the experimental neurology and the methods for the medicamentous treatment of the multiple sclerosis. The method comprises the use of biostimulators, in particular SNC-TTP-cerebral peptide at a dose of 0.01-0.012 mg of the active substance per 1 kg of body mass intraperitoneally, twice with 6-day interval between the injections.
UA95041855A 1995-04-21 1995-04-21 Method for treating multiple sclerosis UA10276A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA95041855A UA10276A (en) 1995-04-21 1995-04-21 Method for treating multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA95041855A UA10276A (en) 1995-04-21 1995-04-21 Method for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
UA10276A true UA10276A (en) 1996-12-25

Family

ID=74552380

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95041855A UA10276A (en) 1995-04-21 1995-04-21 Method for treating multiple sclerosis

Country Status (1)

Country Link
UA (1) UA10276A (en)

Similar Documents

Publication Publication Date Title
RO115700B1 (en) Method of treatment with interferon
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
GEP20002146B (en) Therapeutic Peptide Derivatives
MX9803448A (en) Continuous low-dose cytokine infusion therapy.
GR3031459T3 (en) Wound treatment employing biologically active peptides
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
WO1994027589A3 (en) Antidepressant dosage form
AU5422396A (en) Method for treatment of autoimmune diseases using interferon-tau
EP0660705A4 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
ZA937148B (en) Dioic acids.
HUT77380A (en) Use of a pharmaceutical combination for the treatment of multiple sclerosis (ms) and other demyelinating conditions
GEP19991515B (en) Pharmaceutical Composition
RU2002130192A (en) METHOD FOR TREATING OR PREVENTING OBESITY
GEP20002014B (en) Method for Treatment and/or Prevention of Mania and Bipolar Disorder in Mammals
ZA95679B (en) Products containing G-CSF and TNF binding protein
GEP19970992B (en) Implant for Parenteral Introducing with Controlled Speed
UA10276A (en) Method for treating multiple sclerosis
YU56702A (en) Use of fsh for treating infertility
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
NZ307601A (en) Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
UA10279A (en) Method for treating infantile cerebral paralysis
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
IL126158A0 (en) Method for treating substance abuse
WO1999013894A3 (en) Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
UA7955A (en) Method for treating pulmonary tuberculosis